DESCRIPTION OF BUSINESS (Details Narrative) - USD ($) $ / shares in Units, shares in Millions				12 Months Ended
	Dec. 31, 2018	Oct. 08, 2018	Dec. 15, 2017	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Common stock, par value				$ 0.01	$ 0.01
Investments
Investments, impairment				$ 500,000	$ 500,000
Preprogen Agreement [Member]
Property, Plant and Equipment [Line Items]
Agreement consideration			as consideration for the sale, assignment and transfer of the Purchased Assets (the “Preprogen Transaction”)on the Closing Date, Preprogen(A) paid us $1.0 million (“Cash Amount”) as follows: (i) approximately $38,000 was paid to the City of Portland to payoff certain indebtedness owed by us to the City of Portland, (ii) $65,000 in principal amount of notes held by Preprogen was credited toward the purchase price as a result of the cancellation and termination of those certain promissory notes payable to Preprogen by us, and (iii) the remaining balance was paid to us in cash at closing (the “Closing Balance”); and (B) issued to us that number of membership interests in Preprogen equal to 15% of the issued and outstanding membership interests in Preprogen on a fully diluted basis as of the Closing Date.
Escrow cash received		$ 200,583	$ 400,000
Maximum percentage of funds used for materials cost			50.00%
Common stock, par value			$ 0.01
Exercise price			$ 0.05
Warrant expiry date			Dec. 14, 2022
Percentage of royalty from sale		5.00%
Royalty payments received		$ 200,000
Investments	$ 222,000					$ 0
Investments, impairment	$ 278,000					$ 222,000
Preprogen Agreement [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Number of warrants to purchase			15